PH23246A - Anti-inflammatory phthylazinone - Google Patents

Anti-inflammatory phthylazinone

Info

Publication number
PH23246A
PH23246A PH32079A PH32079DA PH23246A PH 23246 A PH23246 A PH 23246A PH 32079 A PH32079 A PH 32079A PH 32079D A PH32079D A PH 32079DA PH 23246 A PH23246 A PH 23246A
Authority
PH
Philippines
Prior art keywords
class
alkyl
hydrogen
hydroxyl
alkylaminoalkylene
Prior art date
Application number
PH32079A
Other languages
English (en)
Inventor
Telfer Lawson Thomas
Lesley Ann Radov
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of PH23246A publication Critical patent/PH23246A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH32079A 1984-05-17 1985-04-01 Anti-inflammatory phthylazinone PH23246A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/611,310 US4665181A (en) 1984-05-17 1984-05-17 Anti-inflammatory phthalazinones

Publications (1)

Publication Number Publication Date
PH23246A true PH23246A (en) 1989-06-16

Family

ID=24448523

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32079A PH23246A (en) 1984-05-17 1985-04-01 Anti-inflammatory phthylazinone

Country Status (14)

Country Link
US (1) US4665181A (fr)
EP (1) EP0164593B1 (fr)
JP (1) JPS60255777A (fr)
KR (1) KR850008668A (fr)
AT (1) ATE47998T1 (fr)
AU (1) AU570549B2 (fr)
DE (2) DE164593T1 (fr)
DK (1) DK215485A (fr)
FI (1) FI851959L (fr)
IL (1) IL74805A (fr)
NO (1) NO851938L (fr)
NZ (1) NZ211589A (fr)
PH (1) PH23246A (fr)
ZA (1) ZA852387B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE49205T1 (de) * 1984-09-14 1990-01-15 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
US4769369A (en) * 1986-11-14 1988-09-06 Pennwalt Corporation Anti-allergy 1(2H)-phthalazinones
EP0309765A3 (fr) * 1987-09-30 1990-09-26 Fisons Corporation 1(2H)-Phtalazinones comme médicaments cytoprotectifs
DE4103405A1 (de) * 1991-02-05 1992-08-06 Basf Ag 3-amino-benzol-1,2,4,5-tetracarbonsaeuredihydrazide und ihre verwendung als chemilumineszenz-faehige verbindugnen sowie 3-amino-benzol-1,2,4,5-tetracarbonsaeuredianhydride
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
EP0934933A1 (fr) * 1998-02-06 1999-08-11 Byk Gulden Lomberg Chemische Fabrik GmbH Phtalazinones
PT1165085E (pt) * 1999-03-30 2006-10-31 Novartis Ag Derivados de ftalazina para tratar doencas inflamatorias
HUP0203840A3 (en) * 1999-12-30 2005-02-28 Lundbeck & Co As H Method for the preparation of citalopram
US7151102B2 (en) * 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0111078D0 (en) * 2001-05-04 2001-06-27 Novartis Ag Organic compounds
CA2482806A1 (fr) * 2002-04-30 2003-11-13 Kudos Pharmaceuticals Limited Derives de phthalazinone
GB0223341D0 (en) * 2002-10-08 2002-11-13 Groningen Acad Ziekenhuis Organic compounds
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) * 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0419072D0 (en) * 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2006058022A1 (fr) 2004-11-24 2006-06-01 Medpointe Healthcare Inc. Compositions comportant de l'azelastine et leurs procedes d'utilisation
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
US7759337B2 (en) * 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
WO2006103550A1 (fr) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processus de preparation du citalopram et son intermediaire, le 5-aminophthalide
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
US20090181951A1 (en) * 2006-06-15 2009-07-16 Kudos Pharmaceuticals Limited Parp inhibitors
EP2041087A1 (fr) * 2006-06-15 2009-04-01 Kudos Pharmaceuticals Limited Dérivés d'oxybenzamide 2 en tant qu'inhibiteurs d'activité parp
US20090281086A1 (en) * 2006-06-15 2009-11-12 Kudos Pharmaceuticals Limited 2 -oxyheteroarylamide derivatives as parp inhibitors
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
UY30639A1 (es) * 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
MX2010002749A (es) 2007-09-14 2010-06-25 Astrazeneca Ab Derivados de ftalazinona.
CA2702429A1 (fr) * 2007-10-17 2009-04-23 Kudos Pharmaceuticals Limited Forme cristalline l du 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
EA020783B1 (ru) 2008-10-07 2015-01-30 Астразенека Юк Лимитед Фармацевтическая композиция, содержащая 4-[3-(4-циклопропанкарбонилпиперазин-1-карбонил)-4-фторбензил]-2н-фталазин-1-он и коповидон
AR079774A1 (es) * 2009-07-15 2012-02-22 Astrazeneca Ab Compuesto de ftalazinona como forma cristalina c , composicion farmaceutica y usos del mismo
BR112013028886A2 (pt) * 2011-05-10 2016-08-09 Gilead Sciences Inc compostos heterocíclicos fundidos como moduladores dde canal de sódio
US9783529B2 (en) 2013-03-13 2017-10-10 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB808636A (en) * 1955-08-02 1959-02-11 Cassella Farbwerke Mainkur Ag Basically substituted heterocyclic compounds
GB1126669A (en) * 1967-04-28 1968-09-11 Deutsches Hydrierwerke Rodlebe Process for production of basically substituted phthalazones
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
JPS4931683A (fr) * 1972-07-27 1974-03-22
JPS5214788A (en) * 1975-07-21 1977-02-03 Fuji Photo Film Co Ltd Process for preparing phthalazinone and its derivatives
US4134880A (en) * 1978-01-19 1979-01-16 Mitsui Toatsu Chemicals, Incorporated Process for producing an aromatic urethane from nitro compounds, hydroxyl compounds and carbon monoxide using metal-Lewis acid-ammonia catalyst systems
US4334069A (en) * 1978-07-24 1982-06-08 Miles Laboratories, Inc. Chemiluminescent phthalhydrazide-labeled hapten conjugates
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
CA1143733A (fr) * 1979-07-31 1983-03-29 Masao Yoshida Obtention de 7-alcoxycarbonyl-6,8-dimethyl-4- hydroxymethyl-1-phtalazone, et de produits intermediaires

Also Published As

Publication number Publication date
FI851959L (fi) 1985-11-18
AU4087385A (en) 1985-11-21
FI851959A0 (fi) 1985-05-16
ZA852387B (en) 1986-04-30
US4665181A (en) 1987-05-12
DE164593T1 (de) 1986-06-12
DK215485D0 (da) 1985-05-15
IL74805A (en) 1988-07-31
KR850008668A (ko) 1985-12-21
ATE47998T1 (de) 1989-12-15
NO851938L (no) 1985-11-18
JPS60255777A (ja) 1985-12-17
EP0164593A1 (fr) 1985-12-18
IL74805A0 (en) 1985-07-31
EP0164593B1 (fr) 1989-11-15
DE3574253D1 (de) 1989-12-21
AU570549B2 (en) 1988-03-17
DK215485A (da) 1985-11-18
NZ211589A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
PH23246A (en) Anti-inflammatory phthylazinone
JPS6426697A (en) Novel dispersant for oily composition
YU45934B (sh) Postopek za pripravo derivatov piridazinona
AU579116B2 (en) Use of quinoline derivatives for the protection of cultivated plants
ATE39929T1 (de) Salzfreie phosphorbetaine.
AU646849B2 (en) Lubricating oil additives, their preparation and use
RO82014B (ro) Procedeu pentru prepararea unor derivati de 4-chinolona cu activitate antihipertensiva
GB966493A (en) Novel n,n-disubstituted piperazine compounds and their preparation
ES8307209A1 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
AU646027B2 (en) Lubricating oil additives, their preparation and use
ES8403891A1 (es) Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico
EP0236984A3 (en) Syndet soap
RO82381B (ro) Procedeu pentru prepararea esterilor acidului 3-acilazopropionic
SE9003596L (sv) Saett att framstaella etanolamidalkoxilat